Cronos Group Inc. balance sheet
At the end of fiscal 2025, Cronos Group Inc. had total assets of $1.20bn, total liabilities of $54.2m and shareholders' equity of $1.09bn. It held $792m in cash against $0 of debt: net cash of $792m.
Balance sheet
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7 | 24 | 1,200 | 1,078 | 887 | 765 | 669 | 859 | 792 | 467 |
| Receivables | — | 3 | 5 | 9 | 22 | 23 | 14 | 15 | 34 | 37 |
| Inventory | — | 7 | 38 | 44 | 33 | 38 | 30 | 33 | 47 | 53 |
| Total current assets | — | 40 | 1,573 | 1,372 | 1,080 | 960 | 933 | 936 | 944 | 912 |
| Goodwill | 1 | 1 | 214 | 180 | 1 | 1 | 1 | 63 | 66 | 64 |
| Total assets | — | 183 | 2,090 | 1,926 | 1,398 | 1,213 | 1,140 | 1,166 | 1,197 | 1,180 |
| Accounts payable | — | 1 | 9 | 19 | 11 | 11 | 12 | 17 | 12 | 17 |
| Total current liabilities | — | 33 | 333 | 207 | 54 | 68 | 41 | 50 | 48 | 56 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | — | 35 | 341 | 218 | 63 | 72 | 44 | 55 | 54 | 62 |
| Shareholders' equity | 64 | 148 | 1,750 | 1,711 | 1,337 | 1,144 | 1,100 | 1,064 | 1,094 | 1,069 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | — | 47 | 49 | 49 |
| Net debt (negative = net cash) | −7 | −24 | −1,200 | −1,078 | −887 | −765 | −669 | −859 | −792 | −467 |
| Shares outstanding | — | — | — | 360m | 375m | 381m | 381m | 383m | 382m | 371m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 20 | 15 | 19 | 27 | 27 | 34 | 33 | 37 |
| Inventory | 47 | 33 | 35 | 42 | 48 | 47 | 49 | 53 |
| Total current assets | 959 | 936 | 919 | 927 | 922 | 944 | 928 | 912 |
| Goodwill | 38 | 63 | 63 | 67 | 65 | 66 | 65 | 64 |
| Total assets | 1,184 | 1,166 | 1,154 | 1,175 | 1,178 | 1,197 | 1,172 | 1,180 |
| Accounts payable | 7 | 17 | 9 | 12 | 11 | 12 | 10 | 17 |
| Total current liabilities | 40 | 50 | 33 | 38 | 41 | 48 | 42 | 56 |
| Total liabilities | 53 | 55 | 39 | 45 | 46 | 54 | 48 | 62 |
| Shareholders' equity | 1,082 | 1,064 | 1,066 | 1,082 | 1,083 | 1,094 | 1,074 | 1,069 |
| Non-controlling interests and other (assets − liabilities − equity) | 50 | 47 | 48 | 48 | 50 | 49 | 50 | 49 |
| Shares outstanding | 382m | 383m | 385m | 384m | 383m | 382m | 376m | 371m |
Compare with peers
- Kamada LTD balance sheet
- Amarin Corp plc\uk balance sheet
- Biote Corp. balance sheet
- Organigram Global Inc. balance sheet
- Heron Therapeutics, Inc. balance sheet
Head to head: CRON vs KMDAAMRN vs CRONBTMD vs CRONCRON vs OGI
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies